Chinese Fellowship Programme

UICC and BUPA have produced the Quit smoking guide: Less Smoking, Better Business to support employers to set up tobacco cessation initiatives as part of their wider health employee programmes.

The Chinese fellowship programme was launched in a pilot phase in September 2014 as a collaboration between the Union for International Cancer Control and the Chinese Anti-Cancer Association (CACA). The first cycle of fellowships began in June 2015. The UICC-CACA fellowship programme is an innovative endeavour which aims to develop future leaders in cancer research and clinical practice in China. The selected fellows were given the opportunity to train at international centres of excellence around the globe, drawn from the extensive UICC membership base. Host institutions include the MD Anderson Cancer Center, the Fred Hutchinson Cancer Research Center, and the Princess Margaret Cancer Centre.

Awardees from the first two pilot cycles are currently undertaking their fellowships.

Target candidates

Experienced Chinese professionals in cancer control including clinicians and researchers

Duration Clinical observational fellowships of 3 months & Research fellowships of 12 months

Objectives

  • To develop future leaders in cancer research and clinical practice in China
  • To allow Chinese cancer specialists to build their own skills, receive hands-on experience, intellectual stimulation, research guidance, and academic mentorship

Eligibility

  • Clinicians with an MD degree and a minimum of five years of experience
  • Researchers at the PhD level under the age of forty
  • Proficiency in the English language

Selection

  • A Chinese Scientific committee pre-selects suitable candidates for the fellowship programme based on priority areas for China as well as the curriculum vitae and experience of applicants. The final awardees are chosen by an International Selection committee composed of experts in the fields of research and training, as well as fellowship host institution administrators.

Partners:

Last update

Thursday 12 January 2023

Share this page